{"DataElement":{"publicId":"6689315","version":"1","preferredName":"Lung Precancerous Condition Histopathologic Examination Outcome","preferredDefinition":"The result of a precancerous lung tissue examination using light or electron microscopy and employing cytochemical and immunocytochemical stain.","longName":"LUNG_PRE_CA_HISTOPATH_RSLT","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6687917","version":"1","preferredName":"Lung Precancerous Condition Histopathologic Examination","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)_The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","longName":"2399007v1.0:6753443v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"2399007","version":"1","preferredName":"Lung","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.","longName":"C12468","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF1C626B-A28E-1F9E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-29","endDate":null,"createdBy":"HARDINGR","dateCreated":"2005-08-29","modifiedBy":"ONEDATA","dateModified":"2005-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6753443","version":"1","preferredName":"Precancerous Condition Histopathologic Examination","preferredDefinition":"Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed):The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","longName":"C3341:C18190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Precancerous Condition","conceptCode":"C3341","definition":"A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histopathologic Examination","conceptCode":"C18190","definition":"The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8863001C-C2AC-5839-E053-F662850AD2A9","latestVersionIndicator":"Yes","beginDate":"2019-05-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-08","modifiedBy":"ONEDATA","dateModified":"2019-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"85F78071-4FC8-462C-E053-F662850AD9B5","latestVersionIndicator":"Yes","beginDate":"2019-04-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-07","modifiedBy":"KNABLEJ","dateModified":"2020-02-06","changeDescription":"4/25/19 jk released/qualified per review by Sarah M. 4/7/19 jk created for MCL PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6681760","version":"1","preferredName":"Lung Histopathologic Examination Outcome","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains._The result of an action.","longName":"6681760v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Severe Dysplasia","valueDescription":"Severe Dysplasia","ValueMeaning":{"publicId":"2569004","version":"1","preferredName":"Severe Dysplasia","longName":"2569004","preferredDefinition":"A morphologic finding indicating the presence of severe cellular atypia associated with severe architectural changes in a tissue sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Dysplasia","conceptCode":"C8364","definition":"A morphologic finding indicating the presence of severe cellular atypia associated with severe architectural changes in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA99-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-31","modifiedBy":"TAYLORT","dateModified":"2017-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8515C301-9F39-4F95-E053-F662850A2EC4","beginDate":"2019-03-27","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-27","modifiedBy":"ONEDATA","dateModified":"2019-03-27","deletedIndicator":"No"},{"value":"Moderate Dysplasia","valueDescription":"Moderate Dysplasia","ValueMeaning":{"publicId":"2569002","version":"1","preferredName":"Moderate Dysplasia","longName":"2569002","preferredDefinition":"A morphologic finding indicating the presence of moderate cellular atypia associated with moderate architectural changes in a tissue sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate Dysplasia","conceptCode":"C8363","definition":"A morphologic finding indicating the presence of moderate cellular atypia associated with moderate architectural changes in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA97-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-31","modifiedBy":"TAYLORT","dateModified":"2017-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8515C301-9F4E-4F95-E053-F662850A2EC4","beginDate":"2019-03-27","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-27","modifiedBy":"ONEDATA","dateModified":"2019-03-27","deletedIndicator":"No"},{"value":"Mild Dysplasia","valueDescription":"Mild Dysplasia","ValueMeaning":{"publicId":"2569000","version":"1","preferredName":"Mild Dysplasia","longName":"2569000","preferredDefinition":"A morphologic finding indicating the presence of mild cellular atypia associated with mild architectural changes in a tissue sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild Dysplasia","conceptCode":"C8362","definition":"A morphologic finding indicating the presence of mild cellular atypia associated with mild architectural changes in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA95-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-31","modifiedBy":"TAYLORT","dateModified":"2017-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8515C301-9F63-4F95-E053-F662850A2EC4","beginDate":"2019-03-27","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-27","modifiedBy":"ONEDATA","dateModified":"2019-03-27","deletedIndicator":"No"},{"value":"MIA","valueDescription":"Bronchioalveolar Carcinoma","ValueMeaning":{"publicId":"3106712","version":"1","preferredName":"Bronchioalveolar Carcinoma","longName":"3106712","preferredDefinition":"A solitary adenocarcinoma arising from the lung measuring 3 cm or less. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimally Invasive Lung Adenocarcinoma","conceptCode":"C2923","definition":"A solitary adenocarcinoma arising from the lung and measuring 3 cm or less in size. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883834AB-0D26-C6A6-E040-BB89AD431A8D","latestVersionIndicator":"Yes","beginDate":"2010-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-04","modifiedBy":"COOPERM","dateModified":"2019-04-10","changeDescription":"Updated definition to match current NCIt. 4.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86230F68-689A-2B2E-E053-F662850ACFC1","beginDate":"2019-04-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"AAH","valueDescription":"Atypical Adenomatous Lung Hyperplasia","ValueMeaning":{"publicId":"3250153","version":"1","preferredName":"Atypical Adenomatous Lung Hyperplasia","longName":"3250153","preferredDefinition":"A multifocal neoplastic process in the lung parenchyma characterized by the proliferation of atypical alveolar epithelial cells without the presence of significant chronic inflammation.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Adenomatous Lung Hyperplasia","conceptCode":"C5665","definition":"A preinvasive lesion in the lung. It is characterized by the presence of a small, localized proliferation of mildly to moderately atypical type II pneumocytes and/or Clara cells lining alveolar walls and sometimes respiratory bronchioles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6DE8128-E908-E018-E040-BB89AD437315","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86230F68-68AF-2B2E-E053-F662850ACFC1","beginDate":"2019-04-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"AIS","valueDescription":"Lung Adenocarcinoma In Situ","ValueMeaning":{"publicId":"6690848","version":"1","preferredName":"Lung Adenocarcinoma In Situ","longName":"6690848","preferredDefinition":"A localized non-invasive adenocarcinoma of the lung measuring 3 cm or less. It is characterized by a pure lepidic growth pattern and the lack of stromal, vascular, or pleural invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Adenocarcinoma In Situ","conceptCode":"C136486","definition":"A localized non-invasive adenocarcinoma of the lung measuring 3 cm or less. It is characterized by a pure lepidic growth pattern and the lack of stromal, vascular, or pleural invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"865699BE-4470-4C43-E053-F662850AB592","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"874DF43D-294B-6665-E053-F662850A9B42","beginDate":"2019-04-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","deletedIndicator":"No"},{"value":"CIS","valueDescription":"Lung Squamous Cell Carcinoma In Situ","ValueMeaning":{"publicId":"6690852","version":"1","preferredName":"Lung Squamous Cell Carcinoma In Situ","longName":"6690852","preferredDefinition":"A preinvasive bronchial neoplastic lesion affecting the squamous epithelium. It is characterized by the absence of progression of maturation from base to luminal surface, basilar zone expansion with cellular crowding throughout the epithelium, absence of the intermediate zone, and surface flattening confined to the most superficial cells. The nuclear-to-cytoplasmic ratio is often high and variable, the chromatin is coarse and uneven, and mitotic figures are present through full thickness. The cell size may be markedly increased. Anisocytosis and pleomorphism may be present. (Adapted from WHO, 2015)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma In Situ","conceptCode":"C136719","definition":"A preinvasive bronchial neoplastic lesion affecting the squamous epithelium. It is characterized by the absence of progression of maturation from base to luminal surface, basilar zone expansion with cellular crowding throughout the epithelium, absence of the intermediate zone, and surface flattening confined to the most superficial cells. The nuclear-to-cytoplasmic ratio is often high and variable, the chromatin is coarse and uneven, and mitotic figures are present through full thickness. The cell size may be markedly increased. Anisocytosis and pleomorphism may be present. (Adapted from WHO, 2015)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8657219C-EA47-1607-E053-F662850AB9A9","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"874DF43D-295F-6665-E053-F662850A9B42","beginDate":"2019-04-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","deletedIndicator":"No"},{"value":"Not reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CB196FFD-B163-11A5-E053-4EBD850A2133","beginDate":"2021-09-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-03","modifiedBy":"ONEDATA","dateModified":"2021-09-03","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CB196FFD-B16D-11A5-E053-4EBD850A2133","beginDate":"2021-09-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-03","modifiedBy":"ONEDATA","dateModified":"2021-09-03","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559666","version":"1","preferredName":"Other","longName":"2559666","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"LISU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CB196FFD-B177-11A5-E053-4EBD850A2133","beginDate":"2021-09-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-03","modifiedBy":"ONEDATA","dateModified":"2021-09-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6753460","version":"1","preferredName":"Lung Histopathologic Examination Outcome","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.:The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.:The result of an action.","longName":"C12468:C18190:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histopathologic Examination","conceptCode":"C18190","definition":"The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8860D9E1-F059-5A21-E053-F662850AC5AE","latestVersionIndicator":"Yes","beginDate":"2019-05-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-08","modifiedBy":"ONEDATA","dateModified":"2019-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8515C301-9EF3-4F95-E053-F662850A2EC4","latestVersionIndicator":"Yes","beginDate":"2019-03-27","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-27","modifiedBy":"COLBERTM","dateModified":"2021-09-03","changeDescription":"9/1/21 mr Added MIA (minimally invasive adenocarcinoma) and AIS (Adenocarcinoma in situ) as Alt Names to match MCL DD.  11/19/19 jk chg WF to Released per prior comment.  4/25/19 jk released/qualified per review by Sarah M. 4/9/19 jk upd with new PV CUIs. 3/27/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506111","version":"1","longName":"Lung","context":"MCL","ClassificationSchemeItems":[{"publicId":"7781146","version":"1","longName":"Lung PCA Pilot","context":"MCL"},{"publicId":"5858017","version":"1","longName":"Lung Core","context":"MCL"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001792","version":"1","longName":"Lung PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"histopathology_precancer_type","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Pre-cancer type","type":"Preferred Question Text","description":"Pre-cancer type","url":null,"context":"MCL"},{"name":"MCL-PCA-Lung-1","type":"Alternate Question Text","description":"Histopathology precancer type","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"lung_v0_template-1.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86234380-DF5A-71E2-E053-F662850A2183","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-09","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeDescription":"9/2/21 mr Added Ref Doc and AQT.  9/1/21 mr Added MIA (minimally invasive adenocarcinoma) and AIS (Adenocarcinoma in situ) as Alt Names to match MCL DD.  5/10/19 jk upd PQT to standardize question per SME.  4/25/19 jk released/qualified per review by Sarah M. 4/9/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}